- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02335931
Characterization of the Charcot Foot
Follow-up on Cross-sectional Study of Known Population With Charcot Osteoarthropathy - Metabolic, Physiologic and Pathologic Changes
The project concerns a type of very debilitating diabetic foot complications called Charcots osteoarthropathy (COA). This disease is characterized by a rapidly progressing destruction of the load bearing joints, primarily in the feet, resulting in loss of structure and remodeling. Untreated this cascade leads to the collapse of the bones, meaning severe pain and walking disability for the patient. Reconstruction is often very difficult or impossible, and furthermore the collapse can lead to chronic foot ulcers and infections, which in the worst case can be fatal.
Treatment options are currently limited to early diagnosis and physical offloading (immobilisation), assisted wound healing and surgical intervention.
The purpose of this project is to investigate and describe the bone-related factors, which separate COA from other, less acute, diabetic foot changes. The investigators wish to describe the long term consequences of COA - both anatomically, physiologically and biochemically.
The investigators will be doing this in a follow-up investigations on a group of COA patients tested 8 years ago. Little is known of the long term changes to the bone structure after acute COA, and the investigators want to visualize to what extend the bone damage is permanent.
To do this the investigators will be using DXA-scans, x-ray, blood tests including bone markers, neurophysiological tests and occlusion plethysmography.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
København NV, Denmark, 2400
- Bispebjerg Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Followed in the previous study
Exclusion Criteria:
- Unable to attend follow-up
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Charcot foot
Patients with Charcot foot and diabetes mellitus 1 or 2
|
No charcot foot
patients with diabetes mellitus type 1 or 2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Disease progression in the previously affected foot
Time Frame: initiation
|
initiation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Bone mineral density of os. calcaneus
Time Frame: initiation
|
initiation
|
Peripheral neuropathy in the feet
Time Frame: initiation
|
initiation
|
Peripheral blood supply
Time Frame: initiation
|
initiation
|
Altered levels of bone resorption markers
Time Frame: initiation
|
initiation
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Amputations
Time Frame: initiation
|
initiation
|
Diabetes regulation
Time Frame: initiation
|
initiation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rasmus B Jansen, MD, Bispebjerg Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-1-2014-055
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complications of Diabetes Mellitus
-
Hennepin Healthcare Research InstituteCompletedHyperglycemia | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Complications of Diabetes Mellitus | Diabetes-Related ComplicationsUnited States
-
Seoul St. Mary's HospitalUnknownComplications of Diabetes MellitusKorea, Republic of
-
Hospital Alemão Oswaldo CruzJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedComplications of Diabetes MellitusBrazil
-
ANS PharmaUniversity of Campinas, Brazil; Conselho Nacional de Desenvolvimento Científico...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Complications of Diabetes MellitusBrazil
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Giovanni TaveggiaCompletedDiabetic Neuropathies | Complications of Diabetes MellitusItaly
-
University of AlbertaCompletedAtherosclerosis | Complications of Diabetes MellitusCanada
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
University of AarhusCompletedComplications of Transplanted Organs and Tissue | Diabetes Mellitus Nos New OnsetDenmark
-
Meir Medical CenterMeir Hospital, Kfar Saba, IsraelUnknownComplications of Diabetes MellitusIsrael